Bolt Biotherapeutics, Inc. (BOLT) vs Longeveron Inc. (LGVN)
A side-by-side comparison of Bolt Biotherapeutics, Inc. and Longeveron Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BOLT
Bolt Biotherapeutics, Inc.
$3.51HealthcareDelayed quote: Oct 6, 2026, 2:16 PM EDT
LGVN
Longeveron Inc.
$2.37HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — BOLT vs LGVN
growth of $100 · dividends reinvested · last 6yBOLT -99.5% (-58.6%/yr)LGVN -99.7% (-61.2%/yr)BOLT compounded faster over this window
BOLT LGVN
BOLT vs LGVN: by the numbers
- •LGVN is the larger company ($7M vs $7M market cap).
- •Both run net losses; BOLT's is the smaller (-611.47% vs -1977.59% net margin).
Metrics side by side
Valuation
| Metric | BOLT | LGVN |
|---|---|---|
| P/S ratio | 1.44 | 6.09 |
| P/B ratio | 0.53 | 0.69 |
Profitability
| Metric | BOLT | LGVN |
|---|---|---|
| Gross margin | 80.62% | 69.76% |
| Operating margin | -450.07% | -1942.20% |
| Net margin | -611.47% | -1977.59% |
| ROE | -227.37% | -225.67% |
| ROIC | -90.17% | -211.58% |
Growth (annualized)
| Metric | BOLT | LGVN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -21.21% |
| Total return CAGR (5Y) | -57.61% | -62.60% |
Frequently asked
- How have BOLT and LGVN total returns compared?
- Over the past 5 years, BOLT delivered -57.61% and LGVN delivered -62.60% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.